BDBM263519 US9556150, i-7::{2-[5-amino-1-(2-methyl-4- phenoxy-phenyl)-1h-pyrazole- 4-carbonyl]-1h-indol-5-yl}- morpholin-4-yl-methanone
SMILES: Cc1cc(Oc2ccccc2)ccc1-n1ncc(C(=O)c2cc3cc(ccc3[nH]2)C(=O)N2CCOCC2)c1N
InChI Key: InChIKey=YGRJCUYPHRTGLV-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM263519 (US9556150, i-7 | {2-[5-amino-1-(2-methyl-4- phenox...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | 7.15 | n/a |
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent | Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc... | US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S | |||||||||||
More data for this Ligand-Target Pair |